| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/03/2002 | US20020002715 Gene expression cassettes |
| 01/03/2002 | CA2709771A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2648051A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2648046A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2414137A1 Recombinant saccharomyces cerevisiae expressing chimeric glucose transporters |
| 01/03/2002 | CA2413673A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2002 | CA2413547A1 B7-like molecules and uses thereof |
| 01/03/2002 | CA2412256A1 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | CA2412239A1 Cytokine receptor zcytor17 |
| 01/03/2002 | CA2412211A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2412089A1 Prostase protein vaccine comprising derivatised thiol residues and methods for producing said antigen |
| 01/03/2002 | CA2412084A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest |
| 01/02/2002 | EP1165781A2 Protease resistant flint analogs |
| 01/02/2002 | EP1165780A2 Flint polypeptide analogs |
| 01/02/2002 | EP1165772A1 Protein-protein complexes from s. cerevisiae and methods of using same |
| 01/02/2002 | EP1165768A1 METHODS OF OBTAINING FULL-LENGTH NUCLEIC ACID SEQUENCES USING $i(E. COLI) TOPOISOMERASE III AND ITS HOMOLOGS |
| 01/02/2002 | EP1165597A1 Bifunctional molecules for delivery of therapeutics |
| 01/02/2002 | EP1165586A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS |
| 01/02/2002 | EP1165121A2 SUPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF |
| 01/02/2002 | EP1165114A1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 01/02/2002 | CN1329665A Gluocoamylases with N-terminal extensions |
| 01/01/2002 | US6335199 Gene therapy |
| 01/01/2002 | US6335183 Stress proteins and uses therefor |
| 01/01/2002 | CA1341331C Viral vector and recombinant dna coding for one or more structural protein (ha, f and/or np) of a morbillivirus, infected cell culture, resulting proteins, vaccine and antibodies |
| 12/27/2001 | WO2001098515A2 Gene-regulating conjugates |
| 12/27/2001 | WO2001098506A2 Methods and means for regulation of gene expression |
| 12/27/2001 | WO2001098499A1 Antigenic polypeptides |
| 12/27/2001 | WO2001098497A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
| 12/27/2001 | WO2001098490A1 A g-protein coupled receptor |
| 12/27/2001 | WO2001098460A2 Fusion proteins of mycobacterium tuberculosis |
| 12/27/2001 | WO2001098366A2 Enterokinase cleavage sequences and their use |
| 12/27/2001 | WO2001098360A2 Gp354 nucleic acids and polypeptides |
| 12/27/2001 | WO2001098353A2 Secreted proteins |
| 12/27/2001 | WO2001098344A2 Angiogenesis-modulating compositions and uses |
| 12/27/2001 | WO2001098343A2 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 12/27/2001 | WO2001098338A2 Fluorescent proteins |
| 12/27/2001 | WO2001098334A2 Streptococcus antigens |
| 12/27/2001 | WO2001098333A2 Modification of hepatitis b core antigen |
| 12/27/2001 | WO2001098324A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 12/27/2001 | WO2001045738A3 Use of heat shock proteins to enhance production of chemokines by a cell |
| 12/27/2001 | WO2001044467A3 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators |
| 12/27/2001 | WO2001036453A3 Ny-eso-1 nanopeptide derivatives, and uses thereof |
| 12/27/2001 | CA2805216A1 Antigenic polypeptides from staphylococcus |
| 12/27/2001 | CA2414228A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
| 12/27/2001 | CA2414046A1 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 12/27/2001 | CA2413986A1 Gp354 nucleic acids and polypeptides |
| 12/27/2001 | CA2413959A1 Fusion proteins of mycobacterium tuberculosis |
| 12/27/2001 | CA2413468A1 Methods and means for regulation of gene expression |
| 12/27/2001 | CA2413454A1 A g-protein coupled receptor |
| 12/27/2001 | CA2413450A1 Streptococcus antigens |
| 12/27/2001 | CA2412215A1 Angiogenesis-modulating compositions and uses |
| 12/27/2001 | CA2410224A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 12/27/2001 | CA2409778A1 Secreted proteins |
| 12/27/2001 | CA2408630A1 Novel enterokinase cleavage sequences |
| 12/26/2001 | CN1328156A Process for preparing fusion protein used for glucose sensor |
| 12/25/2001 | US6333033 Autoantibody inhibitors |
| 12/25/2001 | CA2220575C Soluble, active hepatitis c virus protease |
| 12/25/2001 | CA2139385C Products containing g-csf and tnf binding protein |
| 12/20/2001 | WO2001096875A2 Hcv antigen/antibody combination assay |
| 12/20/2001 | WO2001096870A2 Immunoassays for anti-hcv antibodies |
| 12/20/2001 | WO2001096867A2 Method for identifying insulin mimics or antagonists |
| 12/20/2001 | WO2001096565A2 Binding agents: chimeric ligand/receptor proteins |
| 12/20/2001 | WO2001096563A1 Scramblase 2 |
| 12/20/2001 | WO2001096562A1 Thyrotropin-releasing hormone receptor-like gpcr (gprfwki) |
| 12/20/2001 | WO2001096393A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/20/2001 | WO2001096390A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096388A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001079259A8 Javelinization of protein antigens to heat shock proteins |
| 12/20/2001 | WO2000060076A3 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 12/20/2001 | CA2413003A1 Immunoassays for anti-hcv antibodies |
| 12/20/2001 | CA2412665A1 Scramblase 2 |
| 12/20/2001 | CA2412521A1 Thyrotropin-releasing hormone receptor-like gpcr (gprfwki) |
| 12/20/2001 | CA2412223A1 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | CA2411278A1 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | CA2410532A1 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/19/2001 | EP1163346A1 Hybrid synthetase, hybrid peptide and composition containing same |
| 12/19/2001 | EP1163342A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/19/2001 | EP1163260A1 Process for partitioning of proteins |
| 12/19/2001 | CN1327480A Enhanced protein production in higher plants by N-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
| 12/18/2001 | US6331415 Methods of producing immunoglobulins, vectors and transformed host cells for use therein |
| 12/18/2001 | US6331302 Protein tyrosine kinase agonist antibodies |
| 12/13/2001 | WO2001094607A2 High level production of p-hydroxybenzoic acid in green plants |
| 12/13/2001 | WO2001094581A1 Tumour suppressor and uses thereof |
| 12/13/2001 | WO2001094580A1 Novel g-protein coupled receptor |
| 12/13/2001 | WO2001094547A2 Molecular delivery vehicle for delivery of selected compounds to targets |
| 12/13/2001 | WO2001094418A2 Leader peptides for enhancing secretion of recombinant protein from a host cell |
| 12/13/2001 | WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | WO2001093983A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | WO2001093913A2 T cell receptor fusions and conjugates and methods of use thereof |
| 12/13/2001 | WO2001093804A2 Hepatitis c virus conjugates |
| 12/13/2001 | WO2001072772A3 Calcium binding regulatory subunit |
| 12/13/2001 | WO2001055103A3 Chimeric neuropeptide y receptors |
| 12/13/2001 | WO2001037881A3 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 12/13/2001 | WO2000032773A9 Compositions and methods for increasing bone mineralization |
| 12/13/2001 | WO2000008043A9 Prevention and treatment of viral disease |
| 12/13/2001 | CA2594659A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591930A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591929A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591814A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591590A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |